Target Group Inc (CBDY)
0.0054
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Target Group Total Assets (Quarterly): 8.841M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.841M |
| September 30, 2023 | 8.327M |
| June 30, 2023 | 9.019M |
| March 31, 2023 | 7.694M |
| December 31, 2022 | 7.566M |
| September 30, 2022 | 10.60M |
| June 30, 2022 | 11.40M |
| March 31, 2022 | 13.27M |
| December 31, 2021 | 13.06M |
| September 30, 2021 | 12.94M |
| June 30, 2021 | 13.58M |
| March 31, 2021 | 13.89M |
| December 31, 2020 | 13.04M |
| September 30, 2020 | 17.25M |
| June 30, 2020 | 15.81M |
| March 31, 2020 | 15.12M |
| December 31, 2019 | 16.46M |
| September 30, 2019 | 21.15M |
| June 30, 2019 | 21.52M |
| March 31, 2019 | 19.94M |
| Date | Value |
|---|---|
| December 31, 2018 | 6.781M |
| September 30, 2018 | 5.172M |
| June 30, 2018 | 0.3793M |
| March 31, 2018 | 0.0006M |
| December 31, 2017 | 0.0001M |
| September 30, 2017 | 0.1417M |
| June 30, 2017 | 0.285M |
| March 31, 2017 | 0.2742M |
| December 31, 2016 | 0.2939M |
| September 30, 2016 | 0.0239M |
| June 30, 2016 | 0.0854M |
| March 31, 2016 | 0.2034M |
| December 31, 2015 | 0.0008M |
| September 30, 2015 | 0.0022M |
| June 30, 2015 | 0.0024M |
| March 31, 2015 | 0.0021M |
| December 31, 2014 | 0.0011M |
| September 30, 2014 | 0.0778M |
| June 30, 2014 | 0.0001M |
| March 31, 2014 | 0.002M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
7.566M
Minimum
Dec 2022
21.52M
Maximum
Jun 2019
13.19M
Average
13.06M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 7.832M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 964.80M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.81M |
| Shareholders Equity (Quarterly) | -6.973M |
| Debt to Equity Ratio | -0.0001 |
| Current Ratio | 0.2121 |